[Prevention of transitory hyperbilirubinemia of the premature and mature newborn infants and of the hemolytic disease of the newborn by an enzyme induction combination: phenobarbital-nikethamide].
D001663:Bilirubin / Q000097:blood; D004790:Enzyme Induction; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D006801:Humans; D006932:Hyperbilirubinemia / Q000517:prevention & control*; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000517:prevention & control*; D007235:Infant, Premature, Diseases / Q000517:prevention & control*; D009552:Nikethamide / Q000627:therapeutic use*; D009963:Orotic Acid / Q000627:therapeutic use; D010634:Phenobarbital / Q000627:therapeutic use*; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System
D012204:Rh-Hr Blood-Group System; D009552:Nikethamide; D009963:Orotic Acid; D001663:Bilirubin; D010634:Phenobarbital
Prophylaxe der transitorischen Hyperbilirubinämidie unreifer und reifer Neugeborener und des Morbus haemolyticus neonatorum durch die Enzyminduktorenkombination Phenobarbital-Nikethamid.